Painchek Ltd (ASX: PCK) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Painchek Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$14.44 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
209.25 million
Earnings per share
-0.043
Dividend per share
N/A
Year To Date Return
-75.86%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Painchek Ltd (ASX: PCK)
Latest News
Healthcare Shares
Junior health-tech firm's shares race to 12-month high on US regulatory clearance
Healthcare Shares
Why did this ASX biotech stock explode 36% today?
Share Gainers
What the heck is going on with the PainChek (ASX:PCK) share price?
Healthcare Shares
The PainChek (ASX:PCK) share price is rising on its latest announcement
Healthcare Shares
Why the Painchek (ASX:PCK) share price is charging 13% higher
Share Gainers
Why Lake Resources, PainChek, Z Energy, & Zip shares are rising today
ASX Share Market News
Why the Painchek (ASX:PCK) share price is edging higher today
ASX Share Market News
Why the Painchek (ASX:PCK) share price lifted today
Share Fallers
PainChek (ASX:PCK) share price lower despite Ramsay (ASX:RHC) partnership
PCK ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Painchek Ltd
PainChek Ltd. engages in the development and commercialisation of mobile medical device applications. The company was founded on August 27, 2010 and is headquartered in Sydney, Australia.
PCK Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 13 Nov 2026 | $0.07 | $0.00 | 0.00% | 25,604 | $0.07 | $0.07 | $0.07 |
| 12 Nov 2026 | $0.07 | $0.00 | 0.00% | 68,517 | $0.07 | $0.07 | $0.07 |
| 11 Nov 2026 | $0.07 | $0.00 | 0.00% | 181,200 | $0.07 | $0.07 | $0.07 |
| 05 Nov 2026 | $0.07 | $0.00 | 0.00% | 83,147 | $0.07 | $0.07 | $0.07 |
| 04 Nov 2026 | $0.07 | $-0.01 | -13.33% | 31,839 | $0.07 | $0.07 | $0.07 |
| 03 Nov 2026 | $0.08 | $0.01 | 14.93% | 21,558 | $0.07 | $0.08 | $0.07 |
| 02 Nov 2026 | $0.07 | $-0.01 | -12.82% | 30,575 | $0.07 | $0.07 | $0.07 |
| 30 Oct 2026 | $0.08 | $0.01 | 14.29% | 54,717 | $0.07 | $0.08 | $0.07 |
| 29 Oct 2026 | $0.07 | $0.00 | 0.00% | 239,770 | $0.07 | $0.07 | $0.07 |
| 28 Oct 2026 | $0.07 | $0.00 | 0.00% | 152,586 | $0.08 | $0.08 | $0.07 |
| 27 Oct 2026 | $0.07 | $0.00 | 0.00% | 320,392 | $0.07 | $0.07 | $0.07 |
| 26 Oct 2026 | $0.07 | $-0.01 | -12.82% | 151,263 | $0.08 | $0.08 | $0.07 |
| 23 Oct 2026 | $0.08 | $-0.01 | -11.36% | 1,049,576 | $0.09 | $0.09 | $0.08 |
| 22 Oct 2026 | $0.09 | $0.00 | 0.00% | 6,420 | $0.09 | $0.09 | $0.09 |
| 21 Oct 2026 | $0.09 | $0.00 | 0.00% | 121,976 | $0.09 | $0.09 | $0.09 |
| 20 Oct 2026 | $0.09 | $0.00 | 0.00% | 32,222 | $0.09 | $0.09 | $0.09 |
| 19 Oct 2026 | $0.09 | $-0.01 | -10.75% | 39,319 | $0.09 | $0.09 | $0.09 |
| 16 Oct 2026 | $0.09 | $0.00 | 0.00% | 241,443 | $0.10 | $0.10 | $0.09 |
| 15 Oct 2026 | $0.09 | $0.00 | 0.00% | 353,884 | $0.10 | $0.10 | $0.09 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 28 Sep 2026 | Adam Davey | Exercise | 48,426 | $4,697 |
Conversion of securities.
|
| 28 Sep 2026 | John Murray | Buy | 96,852 | $9,394 |
Conversion of securities.
|
| 28 Sep 2026 | Cynthia Payne | Buy | 48,426 | $4,697 |
Conversion of securities.
|
| 28 Sep 2026 | Adam Davey | Buy | 48,426 | $4,697 |
Conversion of securities.
|
| 28 Sep 2026 | Cynthia Payne | Exercise | 48,426 | $4,697 |
Conversion of securities. As per announcement on 30/09/2026
|
| 28 Sep 2026 | John Murray | Exercise | 96,852 | $9,394 |
Conversion of securities.
|
| 03 Aug 2026 | Adam Davey | Transfer | 158,304 | $15,197 |
Off-market transfer. Indirect holding update
|
| 03 Aug 2026 | Adam Davey | Transfer | 158,304 | $15,197 |
As advised by the company. Indirect holding update
|
| 03 Aug 2026 | John Murray | Issued | 96,852 | $9,297 |
Issue of securities. 96,852 Rights
|
| 03 Aug 2026 | Adam Davey | Issued | 48,426 | $4,648 |
Issue of securities. 48,426 Performance Rights
|
| 03 Aug 2026 | Ross Harricks | Issued | 48,426 | $4,648 |
Issue of securities. 48,426 Performance Rights
|
| 06 Jul 2026 | Philip Daffas | Transfer | 147,059 | $14,705 |
Off-market transfer. Assuming off market transfer
|
| 06 Jul 2026 | Philip Daffas | Transfer | 147,059 | $14,705 |
Off-market transfer. Assuming off market transfer
|
| 19 Jun 2026 | Cynthia Payne | Issued | 484,261 | $50,847 |
Issue of securities. 484,261 Performance Rights
|
| 19 Jun 2026 | Philip Daffas | Issued | 605,328 | $63,559 |
Issue of securities. 1,276,358 Performance Rights
|
| 22 Dec 2025 | Cynthia Payne | Issued | 29,412 | $10,000 |
Placement.
|
| 22 Dec 2025 | Philip Daffas | Issued | 147,059 | $50,000 |
Placement.
|
| 19 Dec 2025 | John Murray | Expiry | 40,000 | $11,200 |
Options expired.
|
| 19 Dec 2025 | Ross Harricks | Expiry | 104,014 | $29,123 |
Options expired.
|
| 19 Dec 2025 | Philip Daffas | Expiry | 200,000 | $56,000 |
Options expired.
|
| 19 Dec 2025 | Cynthia Payne | Expiry | 18,691 | $5,233 |
Options expired.
|
| 19 Dec 2025 | Adam Davey | Expiry | 76,728 | $21,483 |
Options expired.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Adam Stuart Davey | Non-Executive Director | Sep 2014 |
Mr Davey's expertise spans over 40 years and includes capital raising (both private and public), mergers and acquisitions, asset sales and purchases, transaction due diligence and director's duties. Mr Davey is a Director of Wealth Management at Canaccord Genuity Patersons Limited. Mr Davey has been involved in growing businesses in both the industrial and mining sectors. This has been done through holding various roles within different organizations, including chairman, managing director, non-executive director, and corporate adviser to the board.
|
| Ms Lilian (Lil) Bianchi | Non-Executive ChairmanNon-Executive Director | May 2026 |
Ms Bianchi brings a track record of guiding medical technology companies as they navigate growth inflection points and accelerate global market adoption including the US and Europe. With expertise spanning business transformation, AI and SaaS technologies, governance and capital markets, she has helped lead companies through expansion, commercialization and international growth. Her experience across global corporates, tech start-ups and IPO environments combines board, CEO and senior executive leadership experience with a background in strategy, risk and digital disruption.
|
| Ms Cynthia Payne | Non-Executive Director | Mar 2022 |
Ms Payne has more than 30 years of executive leadership experience and over 25 years as a Director in both NFP and FP boards. Cynthia founded the Anchor Impact Group with its suite of Key-brands - Anchor Excellence including Anchor Policy and Anchor Academy, Sage Study Tours & Impactful-Leaders. She is currently NED for listed entity PainChek (2022-Current), INED Abergeldie Complex Infrastructure (2026- current), Past Board Advisor to Total Construction (2019- 2026), past Director of the Mind Connections Foundation and past INED for the National Heart Foundation (2017-2021). Cynthia also volunteers as an Independent Review Panel member for Business Excellence Australia.
|
| Ms Natalie Sylvia Climo | Company Secretary | Jan 2024 |
-
|
| Ms Karen Holzberger | Chief Executive Officer | Aug 2026 |
-
|
| Iain McAdam | CFO |
-
|
|
| Karen Holzberger | Chief Executive Officer |
-
|
|
| Natalie Sylvia Climo | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> | 14,189,249 | 6.79% |
| Peters Investments Pty Ltd | 13,348,125 | 6.39% |
| BNP Paribas Noms Pty Ltd | 5,390,709 | 2.58% |
| J&E Consulting Pty Ltd | 3,808,272 | 1.82% |
| Dr Kreshnik Hoti | 3,771,742 | 1.80% |
| Mr Mustafa Abdul Wahed Atee | 3,700,313 | 1.77% |
| Cache (Wa) Pty Ltd | 3,198,862 | 1.53% |
| Citicorp Nominees Pty Limited | 2,934,378 | 1.40% |
| Gleneden Nominees Pty Ltd | 2,740,741 | 1.31% |
| Mr Philip Daffas | 2,731,095 | 1.31% |
| Ms Eloise Kathleen Jennings & Mr Andrew John Hopkins <Jennings Hopkins Discret A/C> | 2,567,418 | 1.23% |
| Mr Craig Robert Williamson | 2,554,261 | 1.22% |
| G & G Chilcott Pty Ltd <G & G Chilcott S/Fa/C> | 2,417,652 | 1.16% |
| Grazian Pty Ltd <The Ian Murie Superfund A/C> | 2,250,000 | 1.08% |
| Pointwest Investments Pty Ltd <Micke Family A/C> | 2,050,000 | 0.98% |
| Paranji Super Fund Pty Ltd <Paranji Superfund A/C> | 1,957,526 | 0.94% |
| Mr Eddy Roelof Paul De Vries & Mrs Penelope Gail De Vries <Erp&Pg De Vries Family A/C> | 1,779,054 | 0.85% |
| Ltv Holdings Pty Ltd <Villena Lim Family A/C> | 1,754,856 | 0.84% |
| Mr Rodney James Wellstead | 1,710,675 | 0.82% |
| Mr Allan Graham Jenzen & Mrs Elizabeth Jenzen <Ag & E Jenzen P/L No2 Sf A/C> | 1,680,567 | 0.80% |
